Figure 1
![Figure 1. The progressive changes of hematologic parameters (hemoglobin [Hb], white blood cell count [WBC], and platelet count [PLT]; on the left y-axis) and of JAK2V617F allele burden (percent value; on the right y-axis) in samples collected at different times after AML diagnosis. Clinically relevant events (diagnosis of AML or PV, autologous hematopoietic stem-cell transplantation [HSCT], and onset of pruritus) are marked by arrows on the top of the figure.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/110/13/10.1182_blood-2007-07-103267/3/zh80010810700001.jpeg?Expires=1735597254&Signature=DjjQYPC3uUMdSZ4BpMdkxpsg~gu6cUgPGZeZqFq5XFlqxmvT4cyvz9TrzRTUSIx35NqOYFE686xKYAvoTLGNcENHaA4pd1iUGlBGQagkm7ubnBIfANupgJ6F9Y9DNk7ZLrDU7zJrooKdAoqNtNDfu5JKukXEjwuSW-IY8GA2TD3X23kY7kHi363EQnWiDmWvS9KrYxi0czJKQYmVUBYCff71TONYdhoAUajjkX8lGisfzdUsnKGCWjR8t-pyL3PvmRNb9eu6kwF8m13gBbXgfoxr~RN35Xcq9vZSp79a-R4nf3xY3vZs0tVCITl72uqteMLMFvF2zXcv2u2dbrOhhw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
The progressive changes of hematologic parameters (hemoglobin [Hb], white blood cell count [WBC], and platelet count [PLT]; on the left y-axis) and of JAK2V617F allele burden (percent value; on the right y-axis) in samples collected at different times after AML diagnosis. Clinically relevant events (diagnosis of AML or PV, autologous hematopoietic stem-cell transplantation [HSCT], and onset of pruritus) are marked by arrows on the top of the figure.
